Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study

Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study

Abstract Background Intravascular large B‐cell lymphoma (lVLBCL) is a very rare type of large B‐cell lymphoma. Methods We conducted a retrospective study on IVLBCL patients treated from 2000 to 2016 in LYSA cooperative group centers. Results Sixty‐five patients were identified in 23 centers. Median...

Full description

Bibliographic Details
Main Authors: Antoine Bonnet, Céline Bossard, Ludovic Gabellier, Julien Rohmer, Othman Laghmari, Marie Parrens, Clémentine Sarkozy, Rémy Dulery, Virginie Roland, Francisco Llamas‐Gutierrez, Lucie Oberic, Luc‐Matthieu Fornecker, Laura Bounaix, Bruno Villemagne, Vanessa Szablewski, Sylvain Choquet, Krimo Bouabdallah, Alexandra Traverse‐Glehen, Mohamad Mohty, Laurence Sanhes, Roch Houot, Thomas Gastinne, Christophe Leux, Steven Le Gouill
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Cancer Medicine
Subjects:
autoimmune disorders
BCL2 expression
intravascular lymphoma
nodal involvement
Online Access:https://doi.org/10.1002/cam4.4742

Internet

https://doi.org/10.1002/cam4.4742

Similar Items